Apic Bio
Cambridge, US · Founded 2017 · Delaware corporation · 2 known investors
Find your way into Apic Bio
Sign up to find every way you can get introduced to Apic Bio
- Your email: who you already know at Apic Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Apic Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
JR
John ReillyExecutive
CM
Christian MuellerNamed on SEC filing
Board
JD
Jason DingesBoard director
Investors · 2
ALS Investment FundreportedAmsterdam
How we know: a partner's Signal profile · funding news · Not right? Tell us
Also in the syndicate · 1
Morningsidelead
Reported raises · per SEC filings
Form D private placements$55.4M disclosed across 3 rounds · 2018–2021
▶$8.3MraisedJul 2022 · 2 investors · BiotechnologyRule 506(b)
▶$8.3MraisedJul 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christian MuellerDirector
- Stephanie O'Brien, J.D.Director
- John ReillyExecutive Officer, Director
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- Proceeds to insiders
- $1.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedMay 2021 · 11 investors · BiotechnologyRule 506(b)
▶$4.7MraisedMay 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christian MuellerDirector
- John ReillyExecutive Officer, Director
- Jason DingesDirector
- Offering amount
- $12.7M
- Amount sold
- $4.7M
- Proceeds to insiders
- $1.3M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$42.3MraisedNov 2020 · 13 investors · BiotechnologyRule 506(b)
▶$42.3MraisedNov 2020 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason DingesDirector
- John ReillyExecutive Officer, Director
- Christian MuellerDirector
- Offering amount
- $46.1M
- Amount sold
- $42.3M
- Proceeds to insiders
- $1.1M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Apic Bio's investors?
- Apic Bio's investors include ALS Investment Fund.
- How much funding has Apic Bio raised?
- Apic Bio has disclosed $55.4M raised across 3 rounds.
- Where is Apic Bio headquartered?
- Apic Bio is headquartered in Cambridge, US.